🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral semaglutide 50mg (Rybelsus HD) — OASIS program results Page 3

Oral semaglutide 50mg (Rybelsus HD) — OASIS program results

Dr.Martinez Mon, Jun 8, 2026 at 7:03 AM 12 replies 196 viewsPage 3 of 3
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Jun 8, 2026 at 4:41 PM#11
Dr.PainCLE said:
The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to…

This is exactly what I could not find anywhere else.

50 23nick_newbie, DadBodDave, AmyNC_wife and 47 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Jun 8, 2026 at 6:10 PM#12

Adding the clinical framing, because it changes how the question reads. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

Last edited: Jun 8, 2026 at 10:10 PM
1 24MariaRD
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Jun 8, 2026 at 7:40 PM#13
Dr.SleepRoch said:
Albumin binding above 99% is the whole reason weekly dosing works, and it is also why the trough matters more than the peak.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The trial means are being read too generously in this thread. STEP populations were selected, supported, and titrated by protocol, and the real-world curves are consistently a few points worse. That difference is not noise, it is what happens when you remove the study infrastructure.

2 0DataDave, Dr.GutHealth
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Jun 8, 2026 at 9:09 PM#14

Adding the numbers, since they settle part of this. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

Last edited: Jun 9, 2026 at 1:09 AM
3 1FranDenver, Dr.BariatricHTX, LindaRN_retired
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 8, 2026 at 10:39 PM#15

Moderator note: a couple of off-topic posts removed. No action needed from anybody.

4 2PurityPaulOR, MaxMetOK, MounjBrad and 1 other
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
Oral sema absorption enhancer SNAC — how it works10 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register